Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05399784 · ClinicalTrials.gov registry record · NA
Postpartum Visit Timing and the Effect on Visit Attendance
A NA study of Postpartum Depression and Breastfeeding, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT05399784: Completed NA study of Postpartum Depression and Breastfeeding, sponsored by Women and Infants Hospital of Rhode Island.
NCT05399784 is a NA study of Postpartum Depression and Breastfeeding that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 162 participants, below the 472-participant average among 47 other Postpartum Depression trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05399784, a NA study of Postpartum Depression and Breastfeeding, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess if the addition of an early postpartum visit improves attendance at postpartum visits. We seek to evaluate if an additional early postpartum visit improves patient education, satisfaction, or trust in the clinicians during the postpartum period; all of which may ultimately facilitate improved outcomes. Additionally, we seek to explore patient preferences for postpartum care delivery.
Primary Outcome
The number of times a patient attends a postpartum visit in the first 12 weeks postpartum will be counted
Conditions Studied
Interventions
- BEHAVIORAL Early postpartum visit
- BEHAVIORAL Standard postpartum visit
Study Locations (1)
Rhode Island
- Women & Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
What the finished NCT05399784 record still lists
NCT05399784 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 472-participant average among 47 other Postpartum Depression trials with a reported enrollment target (66% lower).
The record links to 6 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Early postpartum visit is the first listed.
NCT05399784 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05399784 about?
NCT05399784 is a clinical study titled "Postpartum Visit Timing and the Effect on Visit Attendance". The objective of this study is to assess if the addition of an early postpartum visit improves attendance at postpartum visits. We seek to evaluate if an additional early postpartum visit improves patient education, satisfaction, or trust in the clinicians during the postpartum period; all of which ...
What is the current status of trial NCT05399784?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2021-02-01. Estimated completion is 2023-06-01.
What conditions does trial NCT05399784 study?
This clinical trial studies the following conditions: Postpartum Depression, Breastfeeding, Postpartum Weight Retention, Trust, Satisfaction, Patient.
What interventions are being tested in trial NCT05399784?
The interventions under investigation include: Early postpartum visit (BEHAVIORAL), Standard postpartum visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT05399784?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05399784 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05399784's enrollment target sits among peer trials
162 20th of 47 higher than 28 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI